Huber, M. et al. IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc. Natl Acad. Sci. USA 105, 20846-20851

Institut für Medizinische Mikrobiologie und Hygiene, Universität Marburg, 35043 Marburg, Germany.
Proceedings of the National Academy of Sciences (Impact Factor: 9.67). 01/2009; 105(52):20846-51. DOI: 10.1073/pnas.0809077106
Source: PubMed


Differentiation of murine T-helper (Th) 17 cells is induced by antigenic stimulation and the sequential action of the cytokines IL-6, IL-21, and IL-23, along with TGFbeta. Current dogma proposes that IL-6 induces IL-21, which, in a STAT3-dependent manner, amplifies its own transcription, contributes to IL-17 production, and, moreover, promotes the expression of the IL-23 receptor. This, in turn, prepares cells for IL-23-mediated stabilization of the Th17 phenotype. Here we demonstrate that these effects of IL-21 on Th17 differentiation are completely dependent on IFN regulatory factor 4 (IRF4). After culturing in the presence of IL-21 plus TGFbeta, IRF4-deficient (Irf4(-/-)) Th cells showed a profound intrinsic defect in IL-17 production and in the autocrine IL-21 loop. Likewise, the levels of IL-23 receptor and the lineage-specific orphan nuclear receptors RORalpha and RORgammat were diminished, whereas the T regulatory (Treg) transcription factor forkhead box P3 (Foxp3) was strongly up-regulated, consistent with the reciprocal relationship between Th17 and Treg development. Despite this loss of IL-21 functions, IL-21-induced STAT3 activation was unimpaired and induced normal Socs3 expression. Forced expression of Foxp3 in WT cells inhibited IL-21-mediated IL-17 production, suggesting that the increase in Foxp3 contributes to the Irf4(-/-) phenotype. Additionally, the low levels of RORalpha and RORgammat are also partially responsible, because simultaneous overexpression of both proteins restored IL-17 production in Irf4(-/-) cells to some extent. These data highlight IRF4 as a decisive factor during the IL-21-mediated steps of Th17 development by influencing the balance of Foxp3, RORalpha, and RORgammat.

Download full-text


Available from: Azita Mahiny,
  • Source
    • "Further analysis showed that lung CD4+ T cells from Tyk-2(−/−) mice released significantly more IL-3 (Fig. 1d) and IL-9 (Fig. 1e) as well as IL-10 (Fig. 1f and 1g) after ovalbumin challenge. Analysis of the recently found Th9-defining transcription factor interferon-regulatory factor 4 (Irf4), which also regulates Th2 and Th17 cell differentiation2223 also revealed induced expression levels after allergen challenge in Tyk-2(−/−) mice compared to wild-type mice in total lung (Fig. 1h). Finally, the most recognized Th9 transcription factor Pu.124 was also found up-regulated at the mRNA level in the lung of Tyk-2 deficient mice (Fig. 1i). "
    [Show abstract] [Hide abstract]
    ABSTRACT: In a murine model of allergic asthma, we found that Tyk-2((-/-)) asthmatic mice have induced peribronchial collagen deposition, mucosal type mast cells in the lung, IRF4 and hyperproliferative lung Th2 CD4(+) effector T cells over-expressing IL-3, IL-4, IL-5, IL-10 and IL-13. We also observed increased Th9 cells expressing IL-9 and IL-10 as well as T helper cells expressing IL-6, IL-10 and IL-21 with a defect in IL-17A and IL-17F production. This T helper phenotype was accompanied by increased SOCS3 in the lung of Tyk-2 deficient asthmatic mice. Finally, in vivo treatment with rIL-17A inhibited local CD4(+)CD25(+)Foxp3(+) T regulatory cells as well as Th2 cytokines without affecting IL-9 in the lung. These results suggest a role of Tyk-2 in different subsets of T helper cells mediated by SOCS3 regulation that is relevant for the treatment of asthma, cancer and autoimmune diseases.
    Scientific Reports 08/2014; 4:5865. DOI:10.1038/srep05865 · 5.58 Impact Factor
  • Source
    • "IRF4−/− mice had normal STAT3 levels, but RORγT expression was impaired, Foxp3 levels were increased, and the mice had a defective response to IL-6 [68]. In particular, IRF4 has also been shown necessary for IL-21 to promote further production of itself and expression of IL-23R [69], thus propagating the Th17 positive feedback loop. With regard to T1D, it has been shown that a lack of IL-21/IL-21R signaling confers protection against T1D [73]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Th17 and IL-17 play important roles in the clearance of extracellular bacterial and fungal infections. However, strong evidence also implicates the Th17 lineage in several autoimmune disorders including multiple sclerosis, psoriasis, rheumatoid arthritis, inflammatory bowel disease, systemic lupus erythematosus, and asthma. The Th17 subset has also been connected with type I diabetes, although whether it plays a role in the pathogenicity of or protection from the disease remains a controversial issue. In this review we have provided a comprehensive overview of Th17 pathogenicity and function, including novel evidence for a protective role of Th17 cells in conjunction with the microbiota gut flora in T1D onset and progression.
    Clinical and Developmental Immunology 12/2013; 2013(7):986789. DOI:10.1155/2013/986789 · 2.93 Impact Factor
  • Source
    • "+ T cells by IL- 6, IL-1í µí»½, TGF-í µí»½, and IL-23, which upregulate the expression of retinoic acid receptor-related orphan receptor-í µí»¾t (RORí µí»¾t) via activation of signal transducer and activator of transcription-3 (Stat3) and interferon regulatory factor 4 (IRF4) [19] [20]. Other transcriptional factors such as RORa, basic leucine zipper transcription factor (Batf), Runx1, and aryl hydrocarbon receptor (AHR) can also induce Th17 cell polarization when coordinated with RORí µí»¾t [21]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: It is widely accepted that chronic inflammation plays an active role in cancer. Inflammatory immunocytes and related cytokines in the tumor microenvironment are supposed to be a "double-edged sword" in colorectal cancer (CRC) initiation and progression. Interleukin-17 (IL-17), a pleiotropic proinflammatory cytokine, can promote cancer-elicited inflammation and prevent cancer cells from immune surveillance. Despite controversy, IL-17 is generally considered to be a promoter in CRC progression. In this review, we devote to summarize the current progress regarding the role of IL-17 in tumor initiation and progression, as well as the prognostic value in CRC.
    Clinical and Developmental Immunology 12/2013; 2013(1):436307. DOI:10.1155/2013/436307 · 2.93 Impact Factor
Show more